A Phase 1, Dose-escalation, Double-blind, Block-randomized, Controlled Trial of Safety and Efficacy of Neosaxitoxin Alone and in Combination with 0.2% Bupivacaine, with and without Epinephrine, for Cutaneous Anesthesia.
A Phase 1, Dose-escalation, Double-blind, Block-randomized, Controlled Trial of Safety and Efficacy of Neosaxitoxin Alone and in Combination with 0.2% Bupivacaine, with and without Epinephrine, for Cutaneous Anesthesia. Anesthesiology. 2015 Oct; 123(4):873-85.
-
Laura Cornelissen, Ph.D.
-
James Matthew Peyton, M.B.,Ch.B.
-
Roy Peake, Ph.D.
-
Joseph Peter Cravero, M.D.
-
Mark Edward Alexander, M.D.
-
Charles Benjamin Berde, M.D., Ph.D.
-
David Zurakowski, Ph.D.
-
Aykut Bilge, Ph.D., M.D.
-
Mary Ellen McCann, M.D.
-
Mark David Kellogg, Ph.D.
-
Karen Rach Boretsky, M.D.
-
Carolina Donado Rincón, M.D.
-
Kimberly Lobo, M.P.H., M.S.